Target intelligence / Profile preview

POPDC1 antisense RNA 1 (POPDC1-AS1)

Target
POPDC1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

POPDC1 antisense RNA 1 (POPDC1-AS1) is a long non-coding RNA transcribed antisense to the POPDC1 (BVES) gene, located on chromosome 6q21[1][5]. It is part of the class of antisense lncRNAs, which can regulate the expression of their sense gene partners by various mechanisms, including influencing mRNA stability, transcription, or chromatin modification[2][9]. POPDC1-AS1 has been identified as downregulated in colorectal adenocarcinoma, suggesting a role in tumor suppression and a possible functional synergy with other lncRNAs and genes involved in cancer development and progression[3]. The specific mechanistic details and clinical utility of POPDC1-AS1 remain under investigation, and it is not currently considered a direct therapeutic target, druggable entity, or established biomarker in clinical use[3][5]. - POPDC1-AS1 is a non-coding RNA, not a protein or classic drug target such as a receptor or enzyme. - Its biological and disease relevance appears to be predominantly through gene regulation (especially of the adjacent POPDC1/BVES gene, which is itself involved in cell adhesion and tumor suppression)[3][5][7]. - There is no evidence that any drugs directly target POPDC1-AS1, nor established mechanisms of action for therapeutics directed at it. - Most functions and disease associations are inferred from limited cancer expression data and regulatory relationships, not from established biochemical pathway mapping or therapies.

Other names
C6orf112bA99L11.2BVES antisense RNA 1BVES antisense gene protein 1BVES-AS1POPDC1-AS1 (non-protein coding)
02

Biological functions

Potential regulation of POPDC1 (BVES) expressionlikely involved in processes modulated by antisense lncRNAs such as modulating mRNA stability or transcriptional regulationpossible impact on cell proliferation and tumor suppression through regulation of the sense gene
03

Disease associations

Cancer (notably colorectal cancer)Potential roles in other diseases through regulation of POPDC1 expression
04

Biomarkers

POPDC1-AS1 as a potential biomarker for certain cancers (notably colorectal cancer), but more evidence is needed; not established in clinical practice

Beyond the preview

Go deeper on POPDC1 antisense RNA 1 (POPDC1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POPDC1 antisense RNA 1 (POPDC1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call